Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 9, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • systemic lupus erythematosus

Tag: systemic lupus erythematosus

  • Biotechnopedia
  • DNA-Tales

Unravelling the rare case of Kikuchi Fujimoto disease

DNA tales January 12, 2022January 12, 2022 1

– Urvi Agrawal The rarity of some diseases often leads to people confusing its signs and symptoms with those of other abnormalities. Sometimes, this can delay their diagnosis and the initiation of treatment. One such rare disease is the Kikuchi-Fujimoto disease. This disease is often confused with lymphoma or Systemic Lupus Erythematosus (SLE). To attain […]

Read More
  • BiotechToday
  • World

Rituximab induced Thrombocytopenia in a Systemic Lupus Erythematosus patient

BioTech Today July 10, 2021July 9, 2021 1

Saptaparna Dasgupta, Bennett University Rituximab being a revolutionary monoclonal antibody, owing up to the mode of action as a potent therapeutic in targeting CD20 cells, has a strong impact on autoimmune health, including systemic lupus erythematosus. Thrombocytopenia, a rare illness, following rituximab is seen to give rise to haematological malignancy. As autoimmune disorders are rare […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy